APA (7th ed.) Citation

Arians, N., Prigge, E., Nachtigall-Schmitt, T., Reuschenbach, M., Debus, J., Knebel Doeberitz, M. v., & Lindel, K. (2019). Overexpression of p16INK4a serves as prognostic marker in squamous cell vulvar cancer patients treated with radiotherapy irrespective of HPV-status. Frontiers in oncology, 9, . https://doi.org/10.3389/fonc.2019.00891

Chicago Style (17th ed.) Citation

Arians, Nathalie, Elena-Sophie Prigge, Tereza Nachtigall-Schmitt, Miriam Reuschenbach, Jürgen Debus, Magnus von Knebel Doeberitz, and Katja Lindel. "Overexpression of P16INK4a Serves as Prognostic Marker in Squamous Cell Vulvar Cancer Patients Treated with Radiotherapy Irrespective of HPV-status." Frontiers in Oncology 9 (2019). https://doi.org/10.3389/fonc.2019.00891.

MLA (9th ed.) Citation

Arians, Nathalie, et al. "Overexpression of P16INK4a Serves as Prognostic Marker in Squamous Cell Vulvar Cancer Patients Treated with Radiotherapy Irrespective of HPV-status." Frontiers in Oncology, vol. 9, 2019, https://doi.org/10.3389/fonc.2019.00891.